tiprankstipranks
Trending News
More News >
ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H (HK:1541)
:1541
Hong Kong Market

ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H (1541) Income Statement

Compare
3 Followers

ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H Income Statement

Last quarter (Q2 2025), ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H's total revenue was ¥44.01M, an increase of Infinity% from the same quarter last year. In Q2, ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H's net income was ¥-152.59M. See ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21
Total Revenue
¥ 74.15M¥ 386.00K¥ 5.69M¥ 13.81M
Gross Profit
¥ 74.15M¥ 7.70M¥ 5.69M¥ 13.81M
Operating Expenses
¥ 382.19M¥ 372.37M¥ 370.14M¥ 224.27M
Depreciation and Amortization
¥ 12.41M¥ 22.58M¥ 17.62M¥ 13.18M
EBITDA
¥ -295.63M¥ -355.35M¥ -384.49M¥ -718.88M
Operating Income
¥ -308.04M¥ -364.67M¥ -364.45M¥ -210.47M
Other Income/Expenses
¥ -8.55M¥ -14.79M¥ -38.44M¥ -522.48M
Pretax Income
¥ -316.59M¥ -379.46M¥ -402.89M¥ -732.95M
Net Income
¥ -315.86M¥ -379.46M¥ -402.89M¥ -732.95M
Per Share Metrics
Basic EPS
¥ -0.84¥ -1.05¥ -1.08¥ -1.96
Diluted EPS
¥ -0.84¥ -1.05¥ -1.08¥ -1.96
Weighted Average Shares Outstanding
377.15M 361.81M 373.24M 373.24M
Weighted Average Shares Outstanding (Diluted)
377.15M 361.81M 373.24M 373.24M
Currency in CNY

ImmuneOnco Biopharmaceuticals (Shanghai) Inc Class H Earnings and Revenue History